Skip to main content

MoneyWorks4Me

Astec Lifesciences informs about quarterly statement on investor complaints

18 Oct 2016 Evaluate

Astec Lifesciences has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
UPL 536.00
PI Industries 1735.00
Bayer CropScience 3316.50
Sharda Cropchem 685.80
Sumitomo Chem. India 328.60
View more..